FBTCX: Fidelity Advisor® Biotechnology Fund - MutualFunds.com

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Fidelity Advisor® Biotechnology C

FBTCX - Snapshot

Vitals

  • YTD Return 25.7%
  • 3 Yr Annualized Return 15.2%
  • 5 Yr Annualized Return 7.2%
  • Net Assets $2.71 B
  • Holdings in Top 10 56.7%

52 WEEK LOW AND HIGH

$29.37
$18.09
$29.46

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.77%

SALES FEES

  • Front Load N/A
  • Deferred Load 1.00%

BROKERAGE FEES

  • Turnover 66.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $0
  • IRA $500

Fund Classification


Compare FBTCX to Popular Health Care Sector Equity Funds and ETFs

Overview

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

$223.89

-0.39%

$46.04 B

1.08%

$2.43

7.53%

-

$111.35

-0.13%

$24.57 B

1.48%

$1.65

10.48%

-

$101.74

+0.27%

$16.68 B

0.05%

$0.05

24.94%

-

$109.26

+0.05%

$14.12 B

1.17%

$1.27

13.87%

-

$218.27

-0.01%

$14.12 B

1.17%

$2.55

15.31%

-

FBTCX - Profile

Distributions

  • YTD Total Return 25.7%
  • 3 Yr Annualized Total Return 15.2%
  • 5 Yr Annualized Total Return 7.2%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio -0.63%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency None

Fund Details

  • Legal Name
    Fidelity Advisor® Biotechnology Fund
  • Fund Family Name
    Fidelity Investments
  • Inception Date
    Dec 27, 2000
  • Shares Outstanding
    N/A
  • Share Class
    C
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Eirene Kontopoulos

Fund Description

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.


FBTCX - Performance

Return Ranking - Trailing

Period FBTCX Return Category Return Low Category Return High Rank in Category (%)
YTD 25.7% -3.8% 167.5% 20.50%
1 Yr 29.7% 1.8% 148.1% 25.77%
3 Yr 15.2%* 2.7% 51.8% 31.47%
5 Yr 7.2%* -0.5% 34.2% 80.71%
10 Yr 19.2%* 9.6% 21.4% 13.01%

* Annualized

Return Ranking - Calendar

Period FBTCX Return Category Return Low Category Return High Rank in Category (%)
2019 15.6% 3.8% 63.8% 78.62%
2018 -7.0% -49.7% 21.5% 47.45%
2017 24.8% -59.8% 54.4% 22.96%
2016 -24.1% -36.6% 11.6% 89.15%
2015 4.7% -62.4% 27.9% 23.77%

Total Return Ranking - Trailing

Period FBTCX Return Category Return Low Category Return High Rank in Category (%)
YTD 25.7% -3.8% 157.0% 19.25%
1 Yr 28.7% -3.5% 148.1% 23.31%
3 Yr 15.2%* 1.8% 51.8% 27.27%
5 Yr 7.2%* -0.5% 34.2% 76.43%
10 Yr 19.2%* 9.5% 21.4% 13.01%

* Annualized

Total Return Ranking - Calendar

Period FBTCX Return Category Return Low Category Return High Rank in Category (%)
2019 15.6% 3.8% 63.8% 78.62%
2018 -7.0% -25.3% 22.2% 54.74%
2017 24.8% -10.8% 54.4% 24.44%
2016 -24.1% -36.6% 11.6% 95.35%
2015 10.5% -16.6% 27.9% 24.59%

NAV & Total Return History


FBTCX - Holdings

Concentration Analysis

FBTCX Category Low Category High FBTCX % Rank
Net Assets 2.71 B 4.64 M 46 B 19.77%
Number of Holdings 93 24 426 49.42%
Net Assets in Top 10 1.37 B 1.01 M 19.6 B 15.12%
Weighting of Top 10 56.67% 15.4% 77.0% 8.72%

Top 10 Holdings

  1. AbbVie Inc 19.90%
  2. AbbVie Inc 19.19%
  3. AbbVie Inc 19.19%
  4. AbbVie Inc 19.19%
  5. AbbVie Inc 19.19%
  6. AbbVie Inc 19.19%
  7. AbbVie Inc 19.19%
  8. AbbVie Inc 19.19%
  9. AbbVie Inc 19.19%
  10. AbbVie Inc 19.19%

Asset Allocation

Weighting Return Low Return High FBTCX % Rank
Stocks
97.54% 76.86% 100.05% 63.95%
Cash
1.35% -0.28% 12.53% 43.02%
Other
1.11% -1.51% 10.43% 18.02%
Preferred Stocks
0.00% 0.00% 4.75% 85.47%
Convertible Bonds
0.00% 0.00% 0.05% 79.65%
Bonds
0.00% 0.00% 16.11% 80.81%

Stock Sector Breakdown

Weighting Return Low Return High FBTCX % Rank
Healthcare
100.00% 61.64% 100.00% 28.49%
Utilities
0.00% 0.00% 0.00% 79.65%
Technology
0.00% 0.00% 15.86% 81.40%
Real Estate
0.00% 0.00% 6.03% 81.40%
Industrials
0.00% 0.00% 5.94% 82.56%
Financial Services
0.00% 0.00% 3.21% 87.79%
Energy
0.00% 0.00% 0.00% 79.65%
Communication Services
0.00% 0.00% 4.69% 80.23%
Consumer Defense
0.00% 0.00% 33.59% 80.23%
Consumer Cyclical
0.00% 0.00% 1.21% 79.65%
Basic Materials
0.00% 0.00% 3.14% 89.53%

Stock Geographic Breakdown

Weighting Return Low Return High FBTCX % Rank
US
86.07% 56.70% 99.99% 29.07%
Non US
11.47% 0.00% 43.24% 62.21%

FBTCX - Expenses

Operational Fees

FBTCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.77% 0.08% 25.14% 25.30%
Management Fee 0.53% 0.00% 1.25% 26.74%
12b-1 Fee 1.00% 0.00% 1.00% 94.67%
Administrative Fee N/A 0.03% 0.40% N/A

Sales Fees

FBTCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load 1.00% 1.00% 5.00% 80.95%

Trading Fees

FBTCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% 90.24%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FBTCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 66.00% 0.70% 252.00% 80.37%

FBTCX - Distributions

Dividend Yield Analysis

FBTCX Category Low Category High FBTCX % Rank
Dividend Yield 0.00% 0.00% 3.15% 83.72%

Dividend Distribution Analysis

FBTCX Category Low Category High Category Mod
Dividend Distribution Frequency None Annually Semi-Annually Annually

Net Income Ratio Analysis

FBTCX Category Low Category High FBTCX % Rank
Net Income Ratio -0.63% -2.53% 2.53% 86.23%

Capital Gain Distribution Analysis

FBTCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

FBTCX - Fund Manager Analysis

Managers

Eirene Kontopoulos


Start Date

Tenure

Tenure Rank

Jul 15, 2018

2.38

2.4%

Eirene Kontopoulos joined Fidelity Investments in 2007, she has worked as a research analyst and portfolio manager.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.17 23.22 7.36 20.6
Continue to site >
Trending ETFs